Related Experiment Video

Updated: Jul 16, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Hepatitis C virus infection

Björn Fischler1

  • 1Department of Pediatrics, Karolinska University Hospital, Huddinge, SE-141 86 Stockholm, Sweden. bjorn.fischler@karolinska.se

Seminars in Fetal & Neonatal Medicine
|February 27, 2007
PubMed

Insights

Chronic hepatitis C infection affects children globally, with mother-to-child transmission risks around 5%. Antiviral treatments show promise, but pediatricians must monitor interferon

Area of Science:

  • Pediatric Infectious Diseases
  • Hepatology
  • Virology

Background:

  • Chronic hepatitis C infection prevalence in children ranges globally from 0.1% to 15%, with higher rates in endemic regions like Africa.
  • Mother-to-child transmission of hepatitis C virus (HCV) occurs in approximately 5% of cases, with limited current preventative strategies.
  • While liver damage progression in infected children is typically slow, it can accelerate over 15-20 years or with co-existing chronic conditions.

Purpose of the Study:

  • To review the current understanding of chronic hepatitis C infection in the pediatric population.
  • To discuss the implications of vertical transmission and the need for testing in newborns.
  • To evaluate the efficacy and considerations of antiviral treatment in children with hepatitis C.

Main Methods:

  • Literature review of studies on pediatric hepatitis C prevalence, transmission, and treatment.
  • Analysis of data regarding disease progression and risk factors for severe liver damage.
  • Evaluation of existing antiviral treatment regimens, including interferon and ribavirin, in pediatric patients.

Main Results:

  • Hepatitis C infection affects children worldwide, with significant prevalence in certain areas.
  • Vertical transmission is a primary concern, necessitating testing for all infants born to infected mothers.
  • Antiviral treatments, particularly interferon and ribavirin combinations, demonstrate effectiveness comparable to adults, though interferon's impact on growth requires careful pediatric monitoring.

Conclusions:

  • All infants born to mothers with hepatitis C should be tested for the virus.
  • Antiviral therapy is important for managing chronic hepatitis C in children, especially those with risk factors for advanced liver disease.
  • Pediatricians must carefully consider the growth-related side effects of interferon when initiating treatment in children.

More Related Videos

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis10:23

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Published on: April 17, 2017

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...